ALA

SKYX Reports Record First Quarter Sales of $19.0 Million Compared to $18.6 Million for First Quarter 2023 as it Continues to Grow its Market Penetration in the U.S and Canada of its Advanced and Smart Platform Products

Retrieved on: 
Dienstag, Mai 14, 2024
NAHB, Partnership, Tax, Patent, NEC, Investment, Calendar, Bank statement, Safety, Sale, Marketing, General Electric, Consumer Electronics Show, ANSI, AI, National Fire Protection Association, ALA, Depreciation, NFPA, National Electrical Code, International, IBS, Acceleration, Lighting

Generated record first quarter 2024 sales of $19.0 million in revenue compared to $18.6 million for the first quarter of 2023, including sales of its advanced and smart platform plug and play products.

Key Points: 
  • Generated record first quarter 2024 sales of $19.0 million in revenue compared to $18.6 million for the first quarter of 2023, including sales of its advanced and smart platform plug and play products.
  • SKYX’s new and existing patents enable and enhance performance of smart home and AI sensors in addition to home safety sensors.
  • The Company continues to grow its market penetration of its advanced and smart platform technologies product to both retail and commercial segments, through its e-commerce platform of over 60 websites for lighting and home décor.
  • Sales and marketing expenses amounted to $6.5 million during the first quarter of 2024, compared to $5.7 million in the first quarter of 2023.

Innovative Computing Systems Exhibits at Association of Legal Administrators 2024 Conference & Expo in Denver

Retrieved on: 
Dienstag, Mai 14, 2024
Energizer, Convention center, Innovation, Exercise, Conference, ALA, Video game

AUSTIN, Texas, May 14, 2024 (GLOBE NEWSWIRE) -- Innovative Computing Systems , a leading legal technology managed service provider, continues its support of legal professionals’ leadership development by attending and exhibiting at the Association of Legal Administrators 2024 Conference & Expo being held May 19-22 at the Gaylord Rockies Resort & Convention Center in Aurora, Colorado.

Key Points: 
  • AUSTIN, Texas, May 14, 2024 (GLOBE NEWSWIRE) -- Innovative Computing Systems , a leading legal technology managed service provider, continues its support of legal professionals’ leadership development by attending and exhibiting at the Association of Legal Administrators 2024 Conference & Expo being held May 19-22 at the Gaylord Rockies Resort & Convention Center in Aurora, Colorado.
  • Innovative Computing Systems will host three events for attendees.
  • Monday starts with a Morning Energizer exercise session at 6:15 a.m. and ends with an invitation-only reception in the evening.
  • “We are always pleased to support the educational advocacy ALA provides to the law firm market,” says Michael Kemps, CEO of Innovative Computing Systems.

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results

Retrieved on: 
Mittwoch, Mai 8, 2024
Sickle cell disease, T1D, SHR, Cell, CRISPR, Partnership, CD19, CRISPR Therapeutics, Biomarker, Autoimmunity, SCD, LNP, Lupus, Kingdom, Porphobilinogen, ADC, Eye, ANGPTL3, RAAS, PBG, Therapy, Lymphoid leukemia, Vertex Pharmaceuticals, Type 1 diabetes, Pain, Cas9, AHP, Diabetes, Research, ALA, BP, CD70, AGT, Clinical trial, Government, G&A, TDT, Sale, CRSP, ALAS1, European, Disease, Patient, Liver, Gene, Society, Stem cell, Cardiovascular disease, SLE, Pharmaceutical industry

CASGEVY is the first therapy to emerge from a strategic partnership between CRISPR Therapeutics and Vertex Pharmaceuticals established in 2015.

Key Points: 
  • CASGEVY is the first therapy to emerge from a strategic partnership between CRISPR Therapeutics and Vertex Pharmaceuticals established in 2015.
  • CRISPR Therapeutics has two next-generation approaches with the potential to significantly expand the addressable population with SCD and TDT.
  • G&A Expenses: General and administrative expenses were $18.0 million for the first quarter of 2024, compared to $22.4 million for the first quarter of 2023.
  • Collaboration Expense: Collaboration expense, net, was $47.0 million for the first quarter of 2024, compared to $42.2 million for the first quarter of 2023.

CRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing In Vivo Gene Editing Approach

Retrieved on: 
Mittwoch, Mai 8, 2024
Pain, CRSP, Patient, SHR, Cas9, Cell, CRISPR, ALAS1, LNP, AHP, Gene editing, Angiotensin, Paratriathlon, RNA, IOP, ALA, Disease, Porphobilinogen, Liver, CRISPR Therapeutics, Gene, Eye, Society, Trabecular meshwork, MYOC, RAAS, Cardiovascular disease, BP, AGT, Biomarker, PBG, Therapy, Glaucoma

In addition, CRISPR Therapeutics announced the expansion of its in vivo pipeline with two new programs.

Key Points: 
  • In addition, CRISPR Therapeutics announced the expansion of its in vivo pipeline with two new programs.
  • “The expansion of our in vivo pipeline speaks to the scalability of the platform and the exceptional translation capabilities of our team.
  • The addition of two more programs, CTX340 and CTX450, utilizing this LNP delivery technology demonstrates the modularity and scalability of the platform.
  • In today’s presentation, the Company presented data demonstrating efficient and specific delivery to TM cells in mouse, non-human primate, and ex vivo human eyes.

Seven Additional Private Sector Leaders Announce Support for Antimicrobial Use Stewardship Principles in Poultry, Now Includes Over 40% of Global Poultry Meat Production

Retrieved on: 
Mittwoch, Mai 8, 2024
Agriculture, Natural Resources, Pharmaceutical, Health, Infectious Diseases, Supply Chain Management, Food, Beverage, Retail, CPEP, Mortality, Poultry, IPC, Risk, Heifer International, Animal, Global health, AMR, Antimicrobial stewardship, BPC, Cargill, Research, Farmer, ALA, VIPA, Disease, Human, Zoonosis, Tyson Foods, ABPA, International development, TFC, CFC, Multimedia, Infection, Private sector, Diagnosis, PFI, British Poultry Council, Organization, USAID, TBA

By generating support from the global poultry industry of science-based principles to address antimicrobial use, the industry is acting to combat AMR and reduce its impact on global health security.

Key Points: 
  • By generating support from the global poultry industry of science-based principles to address antimicrobial use, the industry is acting to combat AMR and reduce its impact on global health security.
  • These seven organizations join 19 other organizations in endorsing or adopting antimicrobial use stewardship principles that reduce the need to use antimicrobials at the farm level.
  • “By proactively supporting science-based antimicrobial use principles, the private sector is sending a clear message that antimicrobial stewardship is good business,” said Ricardo Santin, IPC President.
  • TRANSFORM’s research portfolio includes 22 trials to study the impact of animal nutrition on priority pathogens and antimicrobial resistant genes.

Introducing St Dalfour's New SuperFruits Line: A Delicious and Nutritious Addition to Your Pantry

Retrieved on: 
Mittwoch, Mai 1, 2024
Sprouts, RD, Whole Foods Market, The Wall Street Journal, Radical, Yogurt, ALA, Sugar, Alpha-Linolenic acid, Antioxidant, Superfood, Fruit, Cell damage, Food preservation

St Dalfour SuperFruits adds natural fruit flavor to a balanced meal without the additives found in traditional jams and jellies.

Key Points: 
  • St Dalfour SuperFruits adds natural fruit flavor to a balanced meal without the additives found in traditional jams and jellies.
  • "As an RD and mom of three kids, this new line of St Dalfour fruit spreads will be stocked in my pantry," says Amidor.
  • St Dalfour SuperFruits is now available at select retailers, including Whole Foods, Sprouts, and other fine grocers.
  • For more information about St Dalfour SuperFruits and to find a retailer near you, visit https://www.stdalfour.com/

EBSCO Information Services and the American Library Association Award Ten Librarians with Scholarships to Attend the 2024 ALA Annual Conference

Retrieved on: 
Dienstag, April 30, 2024
Magnet, Librarian, American Library Association, Travel, PS 90, Partnership, Public library, Conference, Magnet school, ALA, Information services, Environmental studies, Teacher-librarian, Silver, EBSCO Information Services, EBSCO

IPSWICH, Mass. and CHICAGO, April 30, 2024 /PRNewswire-PRWeb/ -- EBSCO Information Services (EBSCO), in partnership with the American Library Association (ALA), has awarded ten scholarships to librarians to attend the 2024 ALA Annual Conference. These scholarships are intended to help librarians defray the cost of travel and other expenses so they can attend more than 500 programs, discussions and sessions from world-class speakers and meet with library vendors. These scholarships allow recipients to learn more about digital content, innovation and leadership and expand their professional development while networking with fellow library professionals.

Key Points: 
  • and CHICAGO, April 30, 2024 /PRNewswire-PRWeb/ -- EBSCO Information Services (EBSCO), in partnership with the American Library Association (ALA), has awarded ten scholarships to librarians to attend the 2024 ALA Annual Conference.
  • These scholarships are intended to help librarians defray the cost of travel and other expenses so they can attend more than 500 programs, discussions and sessions from world-class speakers and meet with library vendors.
  • These scholarships allow recipients to learn more about digital content, innovation and leadership and expand their professional development while networking with fellow library professionals.
  • The scholarship recipients will be honored by EBSCO and ALA representatives during the conference at a scholarship breakfast.

OLLY Launches New Cognitive Health Supplements With 'Focus Buddies Brainy L'OLLY Pops' Including Cognizin® Citicoline

Retrieved on: 
Dienstag, April 23, 2024
Target, Kyowa Kirin, Food, Heart, CSCS, Consumer, Communication, Taste, ALA, Attention, Disease, Crash, Dietary supplement

NEW YORK, April 23, 2024 /PRNewswire-PRWeb/ -- The newest delivery system from OLLY is part of a five-product line of supplements, which includes Focus Buddies Brainy L'OLLY Pops, featuring Cognizin® Citicoline. The Watermelon Berry Burst flavored pop is formulated to support focused attention and healthy brain function*.

Key Points: 
  • NEW YORK, April 23, 2024 /PRNewswire-PRWeb/ -- The newest delivery system from OLLY is part of a five-product line of supplements, which includes Focus Buddies Brainy L'OLLY Pops, featuring Cognizin® Citicoline.
  • The Watermelon Berry Burst flavored pop is formulated to support focused attention and healthy brain function*.
  • The rest of the new Brainy line of supplements offers four varieties of chews and lollipops, including Focused Thinker Brainy Chews, Chill Thinker Brainy Chews, Energized Thinker Brainy Chews, and Mellow Buddies Brainy L'OLLY Pops.
  • For more information about OLLY PBC Focus Buddies L'OLLY Pops with Cognizin®, visit OLLY.com or find them in stores at Target.

SKYX Reports Record Sales of $58.8 Million for 2023 and Fourth Quarter Record Sales of $22.2 Million as it Continues to Enhance its Market Penetration for Both Retail and Pro Segments

Retrieved on: 
Montag, April 1, 2024
ALA, General Electric, Annual report, Tax, NAHB, BelAmi, Acceleration, Partnership, ANSI, International, Sale, Acquisition, National Electrical Code, Consumer Electronics Show, NEC, Investment, Safety, Depreciation, CES, IBS, Lighting, Data aggregation, Marketing, Video game

Generated a record $58.8 million in revenue in 2023, including E-commerce sales, smart home products and advanced plug & play products, as compared to $32,022 in 2022.

Key Points: 
  • Generated a record $58.8 million in revenue in 2023, including E-commerce sales, smart home products and advanced plug & play products, as compared to $32,022 in 2022.
  • Generated a record $22.2 million in revenue in the fourth quarter of 2023.
  • SKYX has started sales to the builder and pro segments and opened over 100 builder and pro accounts during the International Builders’ Show (IBS - NAHB) in Las Vegas.
  • Additionally, our e-commerce website platform continues to enhance the acceleration of marketing, distribution channels, collaborations, and sales to both professional and retail segments.

On Target Laboratories Founder Philip Low Receives Legacy Award from the American Lung Association

Retrieved on: 
Montag, April 1, 2024
Lung cancer, ALA, Organization, Innovation, Biotechnology, Disease, Cancer, Health, Patient, Legacy Award, Research, Laboratory, Surgeon, CVS Health, Prognosis, Purdue University

WEST LAFAYETTE, Ind., April 1, 2024 /PRNewswire/ -- Dr. Philip S. Low, Founder and Chief Science Officer of On Target Laboratories, Inc., will receive the Indiana American Lung Association's (ALA) Legacy Award for his lifetime and innovative work on targeted molecules. The annual Indiana ALA Legacy Award is given to individuals or organizations whose accomplishments are contributing to ending lung cancer and will be presented to Dr. Low at the ALA's "Evening of Promise Gala" in Indianapolis on Saturday, April 13. 

Key Points: 
  • Founder and Purdue University researcher Philip Low to be recognized for his invention of CYTALUX, a fluorescent targeted molecule that illuminates lung cancer cells during surgery
    WEST LAFAYETTE, Ind., April 1, 2024 /PRNewswire/ -- Dr. Philip S. Low, Founder and Chief Science Officer of On Target Laboratories, Inc., will receive the Indiana American Lung Association's (ALA) Legacy Award for his lifetime and innovative work on targeted molecules.
  • Dr. Low invented CYTALUX as part of his founding work with On Target Laboratories, a privately held biotechnology company whose mission is to illuminate cancer so it can be removed completely.
  • "We are proud that our Founder and Chief Science Officer, Dr. Low, is being celebrated for his dedication and innovative work to illuminate cancer during surgery," said Ben Lundgren, Chief Executive Officer of On Target Laboratories.
  • "I am honored to be receiving this year's Legacy Award from the Indiana American Lung Association," said Dr. Low.